ConductScience.org, home

Paper33995336

Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria?

Cai J and 5 others. Front Microbiol, 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria? Papers, record 33995336. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33995336

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria?
PubMed
Journal
Front Microbiol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.48
iCite
Revised in PubMed
2021-05-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cai JJingjing
2Chen SSuilin
3Zhu FFeng
4Lu XXiao
5Liu TTaiping
6Xu WWenyue

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128953967Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells.PLoS Pathog2017https://conductscience.org/library/papers/28953967PubMed
220816843Plasmodium immunomics.Int J Parasitol2011https://conductscience.org/library/papers/20816843PubMed
319246182Mechanism of action of clinically approved adjuvants.Curr Opin Immunol2009https://conductscience.org/library/papers/19246182PubMed
426428458Large screen approaches to identify novel malaria vaccine candidates.Vaccine2015https://conductscience.org/library/papers/26428458PubMed
520098724The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.PLoS Med2010https://conductscience.org/library/papers/20098724PubMed
615784594Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria.Infect Immun2005https://conductscience.org/library/papers/15784594PubMed
727903741Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.J Immunol2017https://conductscience.org/library/papers/27903741PubMed
825913272Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.Lancet2015https://conductscience.org/library/papers/25913272PubMed
920114028Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.Cell Host Microbe2010https://conductscience.org/library/papers/20114028PubMed
1030323025Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.Infect Immun2019https://conductscience.org/library/papers/30323025PubMed
1124029408First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.Vaccine2013https://conductscience.org/library/papers/24029408PubMed
1220628205Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice.J Clin Invest2010https://conductscience.org/library/papers/20628205PubMed
1323136909A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.N Engl J Med2012https://conductscience.org/library/papers/23136909PubMed
1430038217Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes.Nat Med2018https://conductscience.org/library/papers/30038217PubMed
1523929949Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.Science2013https://conductscience.org/library/papers/23929949PubMed
166057225Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.Nature1967https://conductscience.org/library/papers/6057225PubMed
1730962400Transmission-Blocking Vaccines: Old Friends and New Prospects.Infect Immun2019https://conductscience.org/library/papers/30962400PubMed
1821514227A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking.Trends Parasitol2011https://conductscience.org/library/papers/21514227PubMed
1922484134Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.Lancet2012https://conductscience.org/library/papers/22484134PubMed
2020637696Changes in the burden of malaria in sub-Saharan Africa.Lancet Infect Dis2010https://conductscience.org/library/papers/20637696PubMed

See all 101 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41893813Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.Vaccines (Basel)2026https://conductscience.org/library/papers/41893813PubMed
40563989Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions.Biomedicines2025https://conductscience.org/library/papers/40563989PubMed
39847577Malaria: Factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy.PLoS Pathog2025https://conductscience.org/library/papers/39847577PubMed
39695728Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials.Malar J2024https://conductscience.org/library/papers/39695728PubMed
37764974Alternative and Complementary Approaches to Consider for Effective Babesia Vaccine Development.Pathogens2023https://conductscience.org/library/papers/37764974PubMed
36993981Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.Front Immunol2023https://conductscience.org/library/papers/36993981PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33995336

GET https://conductscience.org/api/papers/v1/33995336/references?page=2